The Cooper Companies, Inc. (COO) Average EV/Sales Ratio
The current ev/sales ratio for The Cooper Companies, Inc. (COO) is 3.68x as of Sunday, June 14, 2026, shown against its trailing averages.
Average EV/Sales Ratio Chart
COO EV/Sales Ratio Averages
EV/SALES RATIO CURRENT
3.68x
EV/SALES RATIO TTM
4.15x
EV/SALES RATIO 3Y
5.16x
EV/SALES RATIO 5Y
5.81x
EV/SALES RATIO 10Y
6.14x
EV/SALES RATIO 15Y
5.49x
EV/SALES RATIO 20Y
4.80x
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White